ABEONA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 18, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ABEONA THERAPEUTICS INC. | ||
| Date: March 18, 2024 | By: | /s/ Vishwas Seshadri |
|---|---|---|
| Vishwas Seshadri | ||
| President and Chief Executive Officer | ||
| (Principal Executive Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Date: March 18, 2024 | /s/ Vishwas Seshadri |
|---|---|
| Vishwas Seshadri | |
| President, Chief Executive Officer and Director | |
| (Principal Executive Officer) | |
| Date: March 18, 2024 | /s/ Joseph Vazzano |
| Joseph Vazzano | |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) | |
| Date: March 18, 2024 | /s/ Leila Alland |
| Leila Alland, Director | |
| Date: March 18, 2024 | /s/ Mark J. Alvino |
| Mark J. Alvino, Director | |
| Date: March 18, 2024 | /s/ Michael Amoroso |
| Michael Amoroso, Director | |
| Chairman of the Board | |
| Date: March 18, 2024 | /s/ Faith L. Charles |
| Faith L. Charles, Director | |
| Date: March 18, 2024 | /s/ Christine Silverstein |
| Christine Silverstein, Director | |
| Date: March 18, 2024 | /s/ Donald A. Wuchterl |
| Donald A. Wuchterl, Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.